These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34660159)

  • 1. Outcomes of Clinical Trials on Osteonecrosis of the Jaw.
    Wu BW; Lee KC; Halepas S; Karlis V
    Cureus; 2021 Sep; 13(9):e17984. PubMed ID: 34660159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Hoefert S; Schmitz I; Tannapfel A; Eufinger H
    Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
    Fusco V; Santini D; Armento G; Tonini G; Campisi G
    Expert Opin Drug Saf; 2016 Jul; 15(7):925-35. PubMed ID: 27074901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
    Kün-Darbois JD; Fauvel F
    Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M; Jarnbring F; Törring O
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.
    Migliario M; Mergoni G; Vescovi P; Martino I; Alessio M; Benzi L; Renò F; Fusco V
    Dent J (Basel); 2017 Mar; 5(1):. PubMed ID: 29563419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Factors Affect the Completion and Publication of Dental Implant Trials?
    Lee KC; Wu BW; Chuang SK
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1726-1735. PubMed ID: 32697944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
    Kanwar N; Bakr MM; Meer M; Siddiqi A
    Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the Jaws in Dogs in Previously Irradiated Fields: 13 Cases (1989-2014).
    Nemec A; Arzi B; Hansen K; Murphy BG; Lommer MJ; Peralta S; Verstraete FJ
    Front Vet Sci; 2015; 2():5. PubMed ID: 26664934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review.
    Sacco R; Ball R; Barry E; Akintola O
    Br J Oral Maxillofac Surg; 2021 May; 59(4):398-406. PubMed ID: 33789811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.
    Kim KM; Rhee Y; Kwon YD; Kwon TG; Lee JK; Kim DY
    J Bone Metab; 2015 Nov; 22(4):151-65. PubMed ID: 26713306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
    Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw and dental extractions: A single-center experience.
    Sandhu S; Salous MH; Sankar V; Margalit DN; Villa A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):515-521. PubMed ID: 32723683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on Lancet Oncology.
    Fusco V; Campisi G; de Boissieu P; Monaco F; Baraldi A; Numico G; Bedogni A
    Dent J (Basel); 2018 Sep; 6(3):. PubMed ID: 30200393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.